메뉴 건너뛰기




Volumn 34, Issue 7, 2013, Pages 1043-1048

Conversion ratio between Dysport and Botox in clinical practice: An overview of available evidence

Author keywords

Blepharospasm; Botulinum toxin; Cervical dystonia; Conversion ratio; Hemifacial spasm; Spasticity

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

EID: 84880924303     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-013-1357-1     Document Type: Review
Times cited : (31)

References (28)
  • 1
    • 45549083447 scopus 로고    scopus 로고
    • Therapeutic uses of botulinum toxin: From facial palsy to autonomic disorders
    • 18476790 10.1517/14712598.8.6.791
    • De Maio M (2008) Therapeutic uses of botulinum toxin: from facial palsy to autonomic disorders. Expert Opin Biol Ther 8:791-798
    • (2008) Expert Opin Biol Ther , vol.8 , pp. 791-798
    • De Maio, M.1
  • 2
    • 77954705991 scopus 로고    scopus 로고
    • International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments - Introduction
    • 20633176 10.1111/j.1468-1331.2010.03125.x
    • Esquenazi A, Novak I, Sheean G, Singer BJ, Ward AB (2010) International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments - introduction. Eur J Neurol 17(Suppl 2):1-8
    • (2010) Eur J Neurol , vol.17 , Issue.SUPPL. 2 , pp. 1-8
    • Esquenazi, A.1    Novak, I.2    Sheean, G.3    Singer, B.J.4    Ward, A.B.5
  • 3
    • 79955902288 scopus 로고    scopus 로고
    • Botulinum toxin type A: Exploring new indications
    • 10.1358/dot.2010.46.9.1524356 1:CAS:528:DC%2BC3MXht1Wms7vL
    • Brashear A (2010) Botulinum toxin type A: exploring new indications. Drugs Today (Barc) 46:671-682
    • (2010) Drugs Today (Barc) , vol.46 , pp. 671-682
    • Brashear, A.1
  • 4
    • 67650433813 scopus 로고    scopus 로고
    • Dose equivalence of two commercial preparations of botulinum neurotoxin type A: Time for a reassessment?
    • 19463043 10.1185/03007990903028203 1:CAS:528:DC%2BD1MXnsFKqsbs%3D
    • Wohlfarth K, Sycha T, Ranoux D, Naver H, Caird D (2009) Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment? Curr Med Res Opin 25:1573-1584
    • (2009) Curr Med Res Opin , vol.25 , pp. 1573-1584
    • Wohlfarth, K.1    Sycha, T.2    Ranoux, D.3    Naver, H.4    Caird, D.5
  • 5
    • 79958861460 scopus 로고    scopus 로고
    • ® (incobotulinumtoxinA) for the treatment of blepharospasm
    • 21691580 1:CAS:528:DC%2BC3MXns1Sjtbk%3D
    • ® (incobotulinumtoxinA) for the treatment of blepharospasm. Clin Ophthalmol 5:725-732
    • (2011) Clin Ophthalmol , vol.5 , pp. 725-732
    • Park, J.1    Lee, M.S.2    Harrison, A.R.3
  • 6
    • 84880917543 scopus 로고    scopus 로고
    • Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data
    • 21966203 10.2147/OPTH.S24394 1:CAS:528:DC%2BC3MXhtlamurnO
    • Pickett A (2011) Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data. Clin Ophthalmol 5:1287-1290
    • (2011) Clin Ophthalmol , vol.5 , pp. 1287-1290
    • Pickett, A.1
  • 7
    • 34047207959 scopus 로고    scopus 로고
    • Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia
    • 17385940 10.2165/00003495-200767050-00003 1:CAS:528:DC%2BD2sXlsVCmtbw%3D
    • Jost WH, Blümel J, Grafe S (2007) Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia. Drugs 67:669-683
    • (2007) Drugs , vol.67 , pp. 669-683
    • Jost, W.H.1    Blümel, J.2    Grafe, S.3
  • 8
    • 36549049448 scopus 로고    scopus 로고
    • Pharmacology of therapeutic botulinum toxin preparations
    • 18033601 10.1080/09638280701568296
    • Dressler D, Benecke R (2007) Pharmacology of therapeutic botulinum toxin preparations. Disabil Rehabil 29:1761-1768
    • (2007) Disabil Rehabil , vol.29 , pp. 1761-1768
    • Dressler, D.1    Benecke, R.2
  • 9
    • 77953344039 scopus 로고    scopus 로고
    • Botulinum toxin for treatment of dystonia
    • 20590814 10.1111/j.1468-1331.2010.03058.x
    • Dressler D (2010) Botulinum toxin for treatment of dystonia. Eur J Neurol 17(Suppl 1):88-96
    • (2010) Eur J Neurol , vol.17 , Issue.SUPPL. 1 , pp. 88-96
    • Dressler, D.1
  • 10
    • 0027998242 scopus 로고
    • Potency equivalence of botulinum toxin preparations
    • 7837204 1:STN:280:DyaK2M7jvV2qtQ%3D%3D
    • Hambleton P, Pickett AM (1994) Potency equivalence of botulinum toxin preparations. J R Soc Med 87:719
    • (1994) J R Soc Med , vol.87 , pp. 719
    • Hambleton, P.1    Pickett, A.M.2
  • 11
    • 33947601155 scopus 로고    scopus 로고
    • The protein load of therapeutic botulinum toxins
    • 17388970 10.1111/j.1468-1331.2007.01683.x 1:STN:280: DC%2BD2s7osl2isA%3D%3D
    • Pickett A, O'Keeffe R, Panjwani N (2007) The protein load of therapeutic botulinum toxins. Eur J Neurol 14:e11
    • (2007) Eur J Neurol , vol.14 , pp. 11
    • Pickett, A.1    O'Keeffe, R.2    Panjwani, N.3
  • 12
    • 67349097370 scopus 로고    scopus 로고
    • ®) in volunteers: A double-blind, randomized, dose-ranging study
    • 18854916 10.1007/s00415-008-0031-7 1:CAS:528:DC%2BD1MXislSqsr0%3D
    • ®) in volunteers: a double-blind, randomized, dose-ranging study. J Neurol 255:1932-1939
    • (2008) J Neurol , vol.255 , pp. 1932-1939
    • Wohlfarth, K.1    Schwandt, I.2    Wegner, F.3
  • 13
    • 34147222256 scopus 로고    scopus 로고
    • Neurophysiological double-blind trial of a botulinum neurotoxin type a free of complexing proteins
    • 17414940 10.1097/01.WNF.0000240951.18821.50 1:CAS:528: DC%2BD2sXjvVKhsrk%3D
    • Wohlfarth K, Muller C, Sassin I et al (2007) Neurophysiological double-blind trial of a botulinum neurotoxin type a free of complexing proteins. Clin Neuropharmacol 30:86-94
    • (2007) Clin Neuropharmacol , vol.30 , pp. 86-94
    • Wohlfarth, K.1    Muller, C.2    Sassin, I.3
  • 14
    • 0027984226 scopus 로고
    • Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients
    • 7964805 10.1136/jnnp.57.11.1321 1:STN:280:DyaK2M%2FlsVWjtw%3D%3D
    • Hesse S, Lücke D, Malezic M et al (1994) Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 57:1321-1324
    • (1994) J Neurol Neurosurg Psychiatry , vol.57 , pp. 1321-1324
    • Hesse, S.1    Lücke, D.2    Malezic, M.3
  • 15
    • 0030016259 scopus 로고    scopus 로고
    • Use of botulinum toxin in stroke patients with severe upper limb spasticity
    • 8676154 10.1136/jnnp.61.1.30 1:STN:280:DyaK283ns1elsA%3D%3D
    • Bhakta BB, Cozens JA, Bamford JM, Chamberlain MA (1996) Use of botulinum toxin in stroke patients with severe upper limb spasticity. J Neurol Neurosurg Psychiatry 61:30-35
    • (1996) J Neurol Neurosurg Psychiatry , vol.61 , pp. 30-35
    • Bhakta, B.B.1    Cozens, J.A.2    Bamford, J.M.3    Chamberlain, M.A.4
  • 16
    • 0029951449 scopus 로고    scopus 로고
    • Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial
    • 8628472 10.1212/WNL.46.5.1306 1:STN:280:DyaK283ht1Gltw%3D%3D
    • Simpson DM, Alexander DN, O'Brien CF et al (1996) Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 46:1306-1310
    • (1996) Neurology , vol.46 , pp. 1306-1310
    • Simpson, D.M.1    Alexander, D.N.2    O'Brien, C.F.3
  • 17
    • 0033926243 scopus 로고    scopus 로고
    • Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: A randomised double blind placebo controlled trial
    • 10896696 10.1136/jnnp.69.2.217 1:STN:280:DC%2BD3cvgsFCmsA%3D%3D
    • Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM (2000) Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiatry 69:217-221
    • (2000) J Neurol Neurosurg Psychiatry , vol.69 , pp. 217-221
    • Bhakta, B.B.1    Cozens, J.A.2    Chamberlain, M.A.3    Bamford, J.M.4
  • 18
    • 0033800715 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke
    • 11022071 10.1161/01.STR.31.10.2402 1:CAS:528:DC%2BD3cXnsVKqtrg%3D
    • Bakheit AM, Thilmann AF, Ward AB et al (2000) A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 31:2402-2406
    • (2000) Stroke , vol.31 , pp. 2402-2406
    • Bakheit, A.M.1    Thilmann, A.F.2    Ward, A.B.3
  • 19
    • 0034067174 scopus 로고    scopus 로고
    • Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: A prospective, randomised, double blind, placebo controlled, dose ranging study
    • 10811692 10.1136/jnnp.68.6.707 1:STN:280:DC%2BD3c3ntF2lsg%3D%3D
    • Hyman N, Barnes M, Bhakta B et al (2000) Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry 68:707-712
    • (2000) J Neurol Neurosurg Psychiatry , vol.68 , pp. 707-712
    • Hyman, N.1    Barnes, M.2    Bhakta, B.3
  • 20
    • 0037261997 scopus 로고    scopus 로고
    • A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke
    • 12686794 10.1159/000069495 1:CAS:528:DC%2BD3sXislKjsrk%3D
    • Pittock SJ, Moore AP, Hardiman O et al (2003) A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis 15:289-300
    • (2003) Cerebrovasc Dis , vol.15 , pp. 289-300
    • Pittock, S.J.1    Moore, A.P.2    Hardiman, O.3
  • 21
    • 0141958550 scopus 로고    scopus 로고
    • Is the reduction of spasticity by botulinum toxin a beneficial for the recovery of motor function of arm and hand in stroke patients?
    • 14530623 10.1159/000073058 1:CAS:528:DC%2BD3sXnvV2is7k%3D
    • Woldag H, Hummelsheim H (2003) Is the reduction of spasticity by botulinum toxin a beneficial for the recovery of motor function of arm and hand in stroke patients? Eur Neurol 50:165-171
    • (2003) Eur Neurol , vol.50 , pp. 165-171
    • Woldag, H.1    Hummelsheim, H.2
  • 22
    • 3242735082 scopus 로고    scopus 로고
    • Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke
    • 15241751 10.1016/j.apmr.2003.10.015
    • Childers MK, Brashear A, Jozefczyk P et al (2004) Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke. Arch Phys Med Rehabil 85:1063-1069
    • (2004) Arch Phys Med Rehabil , vol.85 , pp. 1063-1069
    • Childers, M.K.1    Brashear, A.2    Jozefczyk, P.3
  • 23
    • 0000270992 scopus 로고    scopus 로고
    • Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity Study Group
    • 9826992 10.1002/(SICI)1097-4598(1997)6+<208: AID-MUS15>3.0.CO;2-1 1:STN:280:DyaK1M%2FksVahug%3D%3D
    • Brin MF (1997) Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity Study Group. Muscle Nerve Suppl 6:S208-S220
    • (1997) Muscle Nerve Suppl , vol.6
    • Brin, M.F.1
  • 24
    • 0036220846 scopus 로고    scopus 로고
    • Respective potencies of Botox and Dysport: A double blind, randomised, crossover study in cervical dystonia
    • 11909903 1:STN:280:DC%2BD387nslejsQ%3D%3D
    • Ranoux D, Gury C, Fondarai J, Mas JL, Zuber M (2002) Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry 72:459-462
    • (2002) J Neurol Neurosurg Psychiatry , vol.72 , pp. 459-462
    • Ranoux, D.1    Gury, C.2    Fondarai, J.3    Mas, J.L.4    Zuber, M.5
  • 25
    • 6844239534 scopus 로고    scopus 로고
    • A, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia
    • 9436720 10.1136/jnnp.64.1.6 1:STN:280:DyaK1c%2Fpslahsg%3D%3D
    • Odergren T, Hjaltason H, Kaakkola S et al (1998) A, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 64:6-12
    • (1998) J Neurol Neurosurg Psychiatry , vol.64 , pp. 6-12
    • Odergren, T.1    Hjaltason, H.2    Kaakkola, S.3
  • 26
    • 0030794264 scopus 로고    scopus 로고
    • Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm
    • 9143885 10.1007/BF00941758
    • Nüssgens Z, Roggenkämper P (1997) Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm. Graefes Arch Clin Exp Ophthalmol 235:197-199
    • (1997) Graefes Arch Clin Exp Ophthalmol , vol.235 , pp. 197-199
    • Nüssgens, Z.1    Roggenkämper, P.2
  • 27
    • 0030725728 scopus 로고    scopus 로고
    • DYSPORT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A - Dysport and Botox - Assuming a ratio of 4:1
    • 9399229 10.1002/mds.870120627 1:STN:280:DyaK1c%2FmtFKhtQ%3D%3D
    • Sampaio C, Ferreira JJ, Simões F et al (1997) DYSPORT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A - Dysport and Botox - assuming a ratio of 4:1. Mov Disord 12:1013-1018
    • (1997) Mov Disord , vol.12 , pp. 1013-1018
    • Sampaio, C.1    Ferreira, J.J.2    Simões, F.3
  • 28
    • 84863982462 scopus 로고    scopus 로고
    • ® in the management of blepharospasm and hemifacial spasm: A novel paradigm for a never ending story
    • 21710123 10.1007/s10072-011-0672-7
    • ® in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story. Neurol Sci 33:261-267
    • (2012) Neurol Sci , vol.33 , pp. 261-267
    • Bentivoglio, A.R.1    Ialongo, T.2    Bove, F.3    De Nigris, F.4    Fasano, A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.